Literature DB >> 9756034

Chronic ethanol treatment leads to increased ornithine decarboxylase activity: implications for a role of polyamines in ethanol dependence and withdrawal.

M Davidson1, P Wilce.   

Abstract

Recent research has focused on the N-methyl-D-aspartate receptor system as a major site of ethanol action in the brain and specifically on compensatory changes in the expression of the polyamine-sensitive NR2B subunit. Therefore, we examined the effects of chronic ethanol treatment on polyamine homeostasis in the rat brain. Wistar rats were made dependent by ethanol vapor inhalation. This caused a rise in hippocampal ornithine decarboxylase (ODC) activity that was correlated with the appearance of physiological dependence. ODC activity returned to control levels within 3 days of ethanol withdrawal. Enzyme activity also increased in the cerebral cortex, striatum, and cerebellum of the ethanol-dependent rats. The concentration of the polyamines (putrescine, spermidine, and spermine) in the hippocampus was increased in ethanol-dependent rats. Injection of the ODC inhibitor, alpha-difluoromethylornithine (500 mg/kg) at the onset of withdrawal resulted in a significant reduction in the severity of withdrawal behaviors. The level of ODC activity and the severity of withdrawal behaviors were positively correlated. Perturbed polyamine homeostasis may represent an important molecular component in the initiation of ethanol withdrawal behaviors in the ethanol-dependent rat.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9756034

Source DB:  PubMed          Journal:  Alcohol Clin Exp Res        ISSN: 0145-6008            Impact factor:   3.455


  7 in total

Review 1.  Glucocorticoid and polyamine interactions in the plasticity of glutamatergic synapses that contribute to ethanol-associated dependence and neuronal injury.

Authors:  Mark A Prendergast; Patrick J Mulholland
Journal:  Addict Biol       Date:  2011-10-04       Impact factor: 4.280

Review 2.  Neuroprotective and abstinence-promoting effects of acamprosate: elucidating the mechanism of action.

Authors:  Philippe De Witte; John Littleton; Philippe Parot; George Koob
Journal:  CNS Drugs       Date:  2005       Impact factor: 5.749

3.  Investigation of extracellular L-citrulline concentration in the striatum during alcohol withdrawal in rats.

Authors:  M Z Gören; F Aricioglu-Kartal; T Yurdun; I T Uzbay
Journal:  Neurochem Res       Date:  2001-12       Impact factor: 3.996

4.  Long-term ethanol and corticosterone co-exposure sensitize the hippocampal ca1 region pyramidal cells to insult during ethanol withdrawal in an NMDA GluN2B subunit-dependent manner.

Authors:  Tracy R Butler; Jennifer N Berry; Lynda J Sharrett-Field; James R Pauly; Mark A Prendergast
Journal:  Alcohol Clin Exp Res       Date:  2013-07-24       Impact factor: 3.455

Review 5.  Acamprosate: a prototypic neuromodulator in the treatment of alcohol dependence.

Authors:  Barbara J Mason; Charles J Heyser
Journal:  CNS Neurol Disord Drug Targets       Date:  2010-03       Impact factor: 4.388

6.  Agmatine reduces balance deficits in a rat model of third trimester binge-like ethanol exposure.

Authors:  B Lewis; K A Wellmann; S Barron
Journal:  Pharmacol Biochem Behav       Date:  2007-07-25       Impact factor: 3.533

7.  Difluoromethylornithine (DFMO) reduces deficits in isolation-induced ultrasonic vocalizations and balance following neonatal ethanol exposure in rats.

Authors:  Maribel A Rubin; Kristen A Wellmann; Ben Lewis; Ben J Overgaauw; John M Littleton; Susan Barron
Journal:  Pharmacol Biochem Behav       Date:  2008-10-25       Impact factor: 3.533

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.